VCIM

Velan Capital Investment Management Portfolio holdings

AUM $99.9M
1-Year Est. Return 37.46%
This Quarter Est. Return
1 Year Est. Return
+37.46%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$97.2M
AUM Growth
-$18.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1 +$8.32M
2 +$2.86M
3 +$2.73M
4
SCPH
scPharmaceuticals
SCPH
+$2.41M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$2.39M

Top Sells

1 +$4.36M
2 +$1.84M
3 +$1.31M
4
RZLT icon
Rezolute
RZLT
+$1.16M
5
COLL icon
Collegium Pharmaceutical
COLL
+$822K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TENX icon
26
Tenax Therapeutics
TENX
$30.5M
$546K 0.56%
83,333
KPRX icon
27
Kiora Pharmaceuticals
KPRX
$9.3M
$368K 0.38%
122,223
CRBP icon
28
Corbus Pharmaceuticals
CRBP
$237M
$313K 0.32%
59,000
+2,300
RGLS
29
DELISTED
Regulus Therapeutics
RGLS
$140K 0.14%
80,000
+10,000
WVE icon
30
Wave Life Sciences
WVE
$1.24B
$105K 0.11%
13,000
GOSS icon
31
Gossamer Bio
GOSS
$501M
$82.5K 0.08%
75,000
ERAS icon
32
Erasca
ERAS
$686M
$68.5K 0.07%
+50,000
ALEC icon
33
Alector
ALEC
$308M
$67.7K 0.07%
55,000
LRMR icon
34
Larimar Therapeutics
LRMR
$359M
$60.2K 0.06%
28,000
+10,000
PRQR icon
35
ProQR Therapeutics
PRQR
$293M
$59.9K 0.06%
45,000
+4,500
CNTX icon
36
Context Therapeutics
CNTX
$129M
$55.1K 0.06%
90,000
DSGN icon
37
Design Therapeutics
DSGN
$327M
$54K 0.06%
+14,000
ACRS icon
38
Aclaris Therapeutics
ACRS
$206M
$53.5K 0.06%
35,000
+8,000
CTMX icon
39
CytomX Therapeutics
CTMX
$528M
$47.7K 0.05%
75,000
+40,000
TERN icon
40
Terns Pharmaceuticals
TERN
$736M
$46.9K 0.05%
17,000
VTYX icon
41
Ventyx Biosciences
VTYX
$280M
$46K 0.05%
40,000
+5,000
FDMT icon
42
4D Molecular Therapeutics
FDMT
$460M
$38.8K 0.04%
12,000
+2,000
PMVP icon
43
PMV Pharmaceuticals
PMVP
$74.2M
$38.1K 0.04%
35,000
OVID icon
44
Ovid Therapeutics
OVID
$105M
$30.3K 0.03%
97,000
+27,000
KRON
45
DELISTED
Kronos Bio
KRON
$28.9K 0.03%
35,000
NXTC icon
46
NextCure
NXTC
$31.9M
$12K 0.01%
2,083
ELEV
47
DELISTED
Elevation Oncology
ELEV
$11.7K 0.01%
45,000
COLL icon
48
Collegium Pharmaceutical
COLL
$1.07B
-28,685
ENTA icon
49
Enanta Pharmaceuticals
ENTA
$318M
-13,000
FGEN icon
50
FibroGen
FGEN
$42M
-3,200